10.8 Superior Bioavailability of Tacrolimus in Liver Transplant Recipients Treated with Extended-Release LCP-Tacrolimus (Envarsus) Compared to Prolonged-Release Tacrolimus (Advagraf) After 12 Weeks of Controlled Therapy within a Multicentre, Randomised, Controlled Clinical Trial (“EnGraft”)